These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 17099794

  • 1. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J, Martínez García F, Roldán Conesa D, Lorente Salinas I, López Fornás F, Ruiz Gómez J, Gómez Gómez J, Segovia Hernández M, Valdés Chávarri M.
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [Abstract] [Full Text] [Related]

  • 2. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
    Winston DJ, Emmanouilides C, Kroeber A, Hindler J, Bruckner DA, Territo MC, Busuttil RW.
    Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J, Moreillon P, Giddey M, Entenza JM.
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [Abstract] [Full Text] [Related]

  • 4. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Fantin B, Leclercq R, Arthur M, Duval J, Carbon C.
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
    Lorian V, Fernandes F.
    Drugs Exp Clin Res; 1998 Aug; 24(2):73-6. PubMed ID: 9675547
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
    Wang FD, Liu IM, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
    [Abstract] [Full Text] [Related]

  • 8. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
    Martínez F, Martín-Luengo F, García A, Valdés M.
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
    [Abstract] [Full Text] [Related]

  • 9. Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.
    Schutt AC, Bohm NM.
    Ann Pharmacother; 2009 Dec; 43(12):2108-12. PubMed ID: 19887592
    [Abstract] [Full Text] [Related]

  • 10. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM.
    Clin Infect Dis; 2003 Feb 15; 36(4):473-81. PubMed ID: 12567306
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibiotic synergism in enterococcal endocarditis.
    Carrizosa J, Kaye D.
    J Lab Clin Med; 1976 Jul 15; 88(1):132-41. PubMed ID: 819602
    [Abstract] [Full Text] [Related]

  • 13. Quantifying human health risks from virginiamycin used in chickens.
    Cox LA, Popken DA.
    Risk Anal; 2004 Feb 15; 24(1):271-88. PubMed ID: 15028017
    [Abstract] [Full Text] [Related]

  • 14. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
    Werner G, Klare I, Spencker FB, Witte W.
    J Antimicrob Chemother; 2003 Jul 15; 52(1):113-5. PubMed ID: 12805253
    [Abstract] [Full Text] [Related]

  • 15. Combining quinupristin/dalfopristin with other agents for resistant infections.
    Brown J, Freeman BB.
    Ann Pharmacother; 2004 Apr 15; 38(4):677-85. PubMed ID: 14990776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.
    J Antimicrob Chemother; 2003 Sep 15; 52(3):514-7. PubMed ID: 12917251
    [Abstract] [Full Text] [Related]

  • 18. Reduced susceptibility to quinupristin/dalfopristin in Enterococcus faecium in Greece without prior exposure to the agent.
    Karanika M, Prati A, Kiritsi M, Spiliopoulou I, Neonakis I, Anifantaki M, Petinaki E.
    Int J Antimicrob Agents; 2008 Jan 15; 31(1):55-7. PubMed ID: 17923393
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin.
    Thompson RL, Lavin B, Talbot GH.
    South Med J; 2003 Aug 15; 96(8):818-20. PubMed ID: 14515928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.